ImmunityBio Inc (IBRX) Company Profile & Statistics

ImmunityBio Inc
IBRX
(Nasdaq - US)
N/A
4.82
-0.67 (-12.29%)
in:usd•As of: Apr 24, 2024 15:59 UTC -4
After Market:4.85+0.04 (+0.73%)
Open
5.45
High
5.72
Low
4.80

About ImmunityBio Inc

CEO

Richard Adcock

Headquarters

3530 john hopkins court

san diego, ca 92121, united states

Auditor

Ernst & Young LLP

Employees

628

Share Holders

Website

https://immunitybio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

ImmunityBio Inc. is a late-clinical-stage immunotherapy company developing therapies which drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems. ImmunityBio Inc., formerly known as NantKwest Inc., is based in CULVER CITY, Calif.

ImmunityBio Inc Statistics

Valuation Measures

Market Capitalization ²	3.26B
Enterprise Value	3.68B
Enterprise Value/EBITDA (ttm)	-12.19
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	5.38K
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-72356.43%
Profit Margin (ttm)	-163269.80%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-204.79%
Return on Assets (ttm)	-114.56%

Income Statement

Revenue (ttm)	622.00K
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	622.00K
EBITDA (ttm)³	-301.48M
Net Income Avi to Common (ttm)	-583.20M
Diluted EPS (ttm)	-1.16

Share Statistics

Beta (5Y Monthly)	1.23
52-Week Change	104.89%
S&P500 52-Week Change	24.56%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	673.95M
Dividend Yield	0.00%
Float ⁴	112.38M
% Held by Insiders	83.40%
% Held by Institutions	8.58%

Balance Sheet

Total Cash (mrq)	266.46M
Total Cash Per Share (mrq)	0.40
Total Debt (mrq)	681.54M
Total Debt/Equity (mrq)	-116.32%
Current Ratio (mrq)	5.05%
Quick Ratio (mrq)	5.05%
Book Value Per Share (mrq)	-0.87

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.72
Free Cash Flow (ytd)	-397.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ImmunityBio Inc

Trade With A Regulated Broker